155 related articles for article (PubMed ID: 17687643)
1. Akt plays an important role in breast cancer cell chemotaxis to CXCL12.
Zhao M; Mueller BM; DiScipio RG; Schraufstatter IU
Breast Cancer Res Treat; 2008 Jul; 110(2):211-22. PubMed ID: 17687643
[TBL] [Abstract][Full Text] [Related]
2. LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways.
Wu M; Chen Q; Li D; Li X; Li X; Huang C; Tang Y; Zhou Y; Wang D; Tang K; Cao L; Shen S; Li G
J Cell Biochem; 2008 Jan; 103(1):245-55. PubMed ID: 17549698
[TBL] [Abstract][Full Text] [Related]
3. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.
Chinni SR; Sivalogan S; Dong Z; Filho JC; Deng X; Bonfil RD; Cher ML
Prostate; 2006 Jan; 66(1):32-48. PubMed ID: 16114056
[TBL] [Abstract][Full Text] [Related]
4. Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells.
Fernandis AZ; Prasad A; Band H; Klösel R; Ganju RK
Oncogene; 2004 Jan; 23(1):157-67. PubMed ID: 14712221
[TBL] [Abstract][Full Text] [Related]
5. CXCL12 activation of CXCR4 regulates mucosal host defense through stimulation of epithelial cell migration and promotion of intestinal barrier integrity.
Smith JM; Johanesen PA; Wendt MK; Binion DG; Dwinell MB
Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G316-26. PubMed ID: 15358596
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor promotes breast cancer cell chemotaxis in CXCL12 gradients.
Mosadegh B; Saadi W; Wang SJ; Jeon NL
Biotechnol Bioeng; 2008 Aug; 100(6):1205-13. PubMed ID: 18553401
[TBL] [Abstract][Full Text] [Related]
7. Differential functional activation of chemokine receptor CXCR4 is mediated by G proteins in breast cancer cells.
Holland JD; Kochetkova M; Akekawatchai C; Dottore M; Lopez A; McColl SR
Cancer Res; 2006 Apr; 66(8):4117-24. PubMed ID: 16618732
[TBL] [Abstract][Full Text] [Related]
8. SDF-1alpha up-regulates interleukin-6 through CXCR4, PI3K/Akt, ERK, and NF-kappaB-dependent pathway in microglia.
Lu DY; Tang CH; Yeh WL; Wong KL; Lin CP; Chen YH; Lai CH; Chen YF; Leung YM; Fu WM
Eur J Pharmacol; 2009 Jun; 613(1-3):146-54. PubMed ID: 19285061
[TBL] [Abstract][Full Text] [Related]
9. CXCL12/SDF1 expression by breast cancers is an independent prognostic marker of disease-free and overall survival.
Mirisola V; Zuccarino A; Bachmeier BE; Sormani MP; Falter J; Nerlich A; Pfeffer U
Eur J Cancer; 2009 Sep; 45(14):2579-87. PubMed ID: 19646861
[TBL] [Abstract][Full Text] [Related]
10. Procollagen I COOH-terminal fragment induces VEGF-A and CXCR4 expression in breast carcinoma cells.
Palmieri D; Astigiano S; Barbieri O; Ferrari N; Marchisio S; Ulivi V; Volta C; Manduca P
Exp Cell Res; 2008 Jul; 314(11-12):2289-98. PubMed ID: 18570923
[TBL] [Abstract][Full Text] [Related]
11. Blockade of invasion and metastasis of breast cancer cells via targeting CXCR4 with an artificial microRNA.
Liang Z; Wu H; Reddy S; Zhu A; Wang S; Blevins D; Yoon Y; Zhang Y; Shim H
Biochem Biophys Res Commun; 2007 Nov; 363(3):542-6. PubMed ID: 17889832
[TBL] [Abstract][Full Text] [Related]
12. Omega-3 polyunsaturated fatty acids down-modulate CXCR4 expression and function in MDA-MB-231 breast cancer cells.
Altenburg JD; Siddiqui RA
Mol Cancer Res; 2009 Jul; 7(7):1013-20. PubMed ID: 19567784
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic knockout of CXCR4 by a novel recombinant protein TAT/54R/KDEL inhibits tumors metastasis.
Ma WF; Du J; Fu LP; Fang R; Chen HY; Cai SH
Mol Cancer Res; 2009 Oct; 7(10):1613-21. PubMed ID: 19825996
[TBL] [Abstract][Full Text] [Related]
14. Role of CXCL12 in metastasis of human ovarian cancer.
Jiang YP; Wu XH; Xing HY; DU XY
Chin Med J (Engl); 2007 Jul; 120(14):1251-5. PubMed ID: 17697577
[TBL] [Abstract][Full Text] [Related]
15. CXCR4 chemokine receptor engagement modifies integrin dependent adhesion of renal carcinoma cells.
Jones J; Marian D; Weich E; Engl T; Wedel S; Relja B; Jonas D; Blaheta RA
Exp Cell Res; 2007 Nov; 313(19):4051-65. PubMed ID: 17706641
[TBL] [Abstract][Full Text] [Related]
16. Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway.
Sauvé K; Lepage J; Sanchez M; Heveker N; Tremblay A
Cancer Res; 2009 Jul; 69(14):5793-800. PubMed ID: 19584281
[TBL] [Abstract][Full Text] [Related]
17. CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells.
Schabath H; Runz S; Joumaa S; Altevogt P
J Cell Sci; 2006 Jan; 119(Pt 2):314-25. PubMed ID: 16390867
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of PKCzeta expression inhibits chemotaxis signal transduction in human lung cancer cells.
Liu Y; Wang B; Wang J; Wan W; Sun R; Zhao Y; Zhang N
Lung Cancer; 2009 Feb; 63(2):210-8. PubMed ID: 18701187
[TBL] [Abstract][Full Text] [Related]
19. Blocking on the CXCR4/mTOR signalling pathway induces the anti-metastatic properties and autophagic cell death in peritoneal disseminated gastric cancer cells.
Hashimoto I; Koizumi K; Tatematsu M; Minami T; Cho S; Takeno N; Nakashima A; Sakurai H; Saito S; Tsukada K; Saiki I
Eur J Cancer; 2008 May; 44(7):1022-9. PubMed ID: 18375114
[TBL] [Abstract][Full Text] [Related]
20. Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer.
Dewan MZ; Ahmed S; Iwasaki Y; Ohba K; Toi M; Yamamoto N
Biomed Pharmacother; 2006 Jul; 60(6):273-6. PubMed ID: 16828253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
